Celyad Oncology SA (CYAD.BR)

EUR 0.71

(-7.42%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 16.28 Million 19.71 Million 79.94 Million 66.08 Million 89.83 Million 94.29 Million
Total Current Assets 11.12 Million 14.82 Million 34.29 Million 19.7 Million 42.83 Million 51.69 Million
Cash And Short Term Investments 7 Million 12.44 Million 30.01 Million 17.23 Million 39.33 Million 49.73 Million
Cash and Cash Equivalents 7 Million 12.44 Million 30.01 Million 17.23 Million 39.33 Million 40.54 Million
Short Term Investments - - - - - 9.19 Million
Net Receivables 380 Thousand 1.25 Million 2.34 Million 907 Thousand 2.7 Million 367 Thousand
Inventory 1.26 Million 1.00 - 1.56 Million 1.00 1.00
Other Current Assets 2.47 Million 1.12 Million 1.93 Million 1000.00 796 Thousand 1.58 Million
Total Non-Current Assets 5.16 Million 4.89 Million 45.65 Million 46.37 Million 47 Million 42.6 Million
Net PPE 1.83 Million 309 Thousand 3.24 Million 4.11 Million 5.06 Million 3.01 Million
Good Will And Intangible Assets 48 Thousand 864 Thousand 36.16 Million 36.17 Million 36.19 Million 36.16 Million
Good Will - - 883 Thousand 883 Thousand 883 Thousand 883 Thousand
Intangible Assets 48 Thousand 864 Thousand 35.28 Million 35.28 Million 35.31 Million 35.28 Million
Long-Term Investments 2.8 Million - 2.2 Million 5.79 Million 5.48 Million 3.21 Million
Tax Assets -2.46 Million - -2.2 Million -5.79 Million -5.48 Million -3.21 Million
Other Non Current Assets 2.94 Million 3.71 Million 6.23 Million 6.08 Million 5.74 Million 3.42 Million
Other Assets - - - - - -
Total Liabilities 9.97 Million 15.39 Million 36.3 Million 35.09 Million 44.21 Million 38.71 Million
Total Current Liabilities 2.93 Million 10.42 Million 13.82 Million 11.83 Million 11.92 Million 9.64 Million
Account Payables 1.24 Million 4.75 Million 6.61 Million 4.73 Million 6.96 Million 5.91 Million
Tax Payables - - - - - 1.35 Million
Short Term Debt 156 Thousand 137 Thousand 902 Thousand 1.11 Million 1.35 Million 765 Thousand
Deferred Revenue 509 Thousand 1.32 Million 1.45 Million 2.2 Million 346 Thousand 276 Thousand
Other Current Liabilities 1.02 Million 4.21 Million 4.85 Million 3.77 Million 3.24 Million 2.69 Million
Total Non Current Liabilities 7.04 Million 4.97 Million 22.47 Million 23.25 Million 32.29 Million 29.06 Million
Long-Term Debt 902 Thousand 118 Thousand 1.73 Million 2.52 Million 3 Million 881 Thousand
Deferred Revenue Non Current 4.5 Million 4.58 Million 5.85 Million 4.22 Million 4.13 Million 2.86 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 737 Thousand 271 Thousand 164 Thousand 371 Thousand 25.15 Million 22.1 Million
Other Liabilities - - - - - -
Total Equity 6.3 Million 4.31 Million 43.63 Million 30.99 Million 45.61 Million 55.59 Million
Stock Holders Equity 6.3 Million 4.31 Million 43.63 Million 30.99 Million 45.61 Million 55.59 Million
Common Stock 32.94 Million 78.58 Million 78.58 Million 48.51 Million 48.51 Million 41.55 Million
Retained Earnings -358.37 Million -349.94 Million -308.99 Million -91.82 Million -74.42 Million -217.77 Million
Accumulated other comprehensive income 331.72 Million 269.36 Million 267.73 Million 30.95 Million 28.18 Million 25.66 Million
Common Stock Equity 6.3 Million 4.31 Million 43.63 Million 30.99 Million 45.61 Million 55.59 Million
Capital Lease Obligation 1.05 Million 255 Thousand 2.63 Million 3.6 Million 4.13 Million 1.13 Million
Total Investments 2.8 Million - 2.2 Million 5.79 Million 5.48 Million 9.19 Million
Total Debt 902 Thousand 255 Thousand 2.63 Million 3.63 Million 4.36 Million 1.64 Million
Net Debt -6.1 Million -12.19 Million -27.38 Million -13.59 Million -34.97 Million -38.89 Million

Balance Sheet Charts